Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1988 1
1991 1
1998 1
2000 2
2008 2
2010 4
2011 3
2012 6
2013 1
2014 2
2015 6
2016 5
2017 4
2018 8
2019 6
2020 8
2021 7
Text availability
Article attribute
Article type
Publication date

Search Results

65 results
Results by year
Filters applied: . Clear all
Page 1
ILC2-driven innate immune checkpoint mechanism antagonizes NK cell antimetastatic function in the lung.
Schuijs MJ, Png S, Richard AC, Tsyben A, Hamm G, Stockis J, Garcia C, Pinaud S, Nicholls A, Ros XR, Su J, Eldridge MD, Riedel A, Serrao EM, Rodewald HR, Mack M, Shields JD, Cohen ES, McKenzie ANJ, Goodwin RJA, Brindle KM, Marioni JC, Halim TYF. Schuijs MJ, et al. Among authors: goodwin rja. Nat Immunol. 2020 Sep;21(9):998-1009. doi: 10.1038/s41590-020-0745-y. Epub 2020 Aug 3. Nat Immunol. 2020. PMID: 32747815 Free PMC article.
Microbiome-derived carnitine mimics as previously unknown mediators of gut-brain axis communication.
Hulme H, Meikle LM, Strittmatter N, van der Hooft JJJ, Swales J, Bragg RA, Villar VH, Ormsby MJ, Barnes S, Brown SL, Dexter A, Kamat MT, Komen JC, Walker D, Milling S, Osterweil EK, MacDonald AS, Schofield CJ, Tardito S, Bunch J, Douce G, Edgar JM, Edrada-Ebel R, Goodwin RJA, Burchmore R, Wall DM. Hulme H, et al. Among authors: goodwin rja. Sci Adv. 2020 Mar 11;6(11):eaax6328. doi: 10.1126/sciadv.aax6328. eCollection 2020 Mar. Sci Adv. 2020. PMID: 32195337 Free PMC article.
The amino acid transporter SLC7A5 is required for efficient growth of KRAS-mutant colorectal cancer.
Najumudeen AK, Ceteci F, Fey SK, Hamm G, Steven RT, Hall H, Nikula CJ, Dexter A, Murta T, Race AM, Sumpton D, Vlahov N, Gay DM, Knight JRP, Jackstadt R, Leach JDG, Ridgway RA, Johnson ER, Nixon C, Hedley A, Gilroy K, Clark W, Malla SB, Dunne PD, Rodriguez-Blanco G, Critchlow SE, Mrowinska A, Malviya G, Solovyev D, Brown G, Lewis DY, Mackay GM, Strathdee D, Tardito S, Gottlieb E; CRUK Rosetta Grand Challenge Consortium, Takats Z, Barry ST, Goodwin RJA, Bunch J, Bushell M, Campbell AD, Sansom OJ. Najumudeen AK, et al. Among authors: goodwin rja. Nat Genet. 2021 Jan;53(1):16-26. doi: 10.1038/s41588-020-00753-3. Epub 2021 Jan 7. Nat Genet. 2021. PMID: 33414552
Mass Spectrometry Imaging in Oncology Drug Discovery.
Goodwin RJ, Bunch J, McGinnity DF. Goodwin RJ, et al. Adv Cancer Res. 2017;134:133-171. doi: 10.1016/bs.acr.2016.11.005. Epub 2017 Jan 10. Adv Cancer Res. 2017. PMID: 28110649 Review.
Universal Sample Preparation Unlocking Multimodal Molecular Tissue Imaging.
Dannhorn A, Kazanc E, Ling S, Nikula C, Karali E, Serra MP, Vorng JL, Inglese P, Maglennon G, Hamm G, Swales J, Strittmatter N, Barry ST, Sansom OJ, Poulogiannis G, Bunch J, Goodwin RJ, Takats Z. Dannhorn A, et al. Among authors: goodwin rj. Anal Chem. 2020 Aug 18;92(16):11080-11088. doi: 10.1021/acs.analchem.0c00826. Epub 2020 Jul 27. Anal Chem. 2020. PMID: 32519547
High-resolution 3D visualization of nanomedicine distribution in tumors.
Moss JI, Barjat H, Emmas SA, Strittmatter N, Maynard J, Goodwin RJA, Storm G, Lammers T, Puri S, Ashford MB, Barry ST. Moss JI, et al. Among authors: goodwin rja. Theranostics. 2020 Jan 1;10(2):880-897. doi: 10.7150/thno.37178. eCollection 2020. Theranostics. 2020. PMID: 31903157 Free PMC article.
Mass spectrometry imaging in drug development.
Nilsson A, Goodwin RJ, Shariatgorji M, Vallianatou T, Webborn PJ, Andrén PE. Nilsson A, et al. Among authors: goodwin rj. Anal Chem. 2015 Feb 3;87(3):1437-55. doi: 10.1021/ac504734s. Epub 2015 Jan 14. Anal Chem. 2015. PMID: 25526173 Review. No abstract available.
65 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page